Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Wiebke Arlt
View PDFchevron_right
Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Henrik Falhammar
The Journal of Clinical Endocrinology & Metabolism, 2007
View PDFchevron_right
Metabolic evaluation of young women with congenital adrenal hyperplasia
Lilia Li
Arquivos Brasileiros de Endocrinologia & Metabologia, 2011
View PDFchevron_right
Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Henrik Falhammar
Journal of the Endocrine Society
View PDFchevron_right
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Wiebke Arlt
Journal of Clinical …, 2010
View PDFchevron_right
Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
Wiebke Arlt
European Journal of Endocrinology, 2013
View PDFchevron_right
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency
Henrik Falhammar
European journal of endocrinology, 2019
View PDFchevron_right
Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy
John Monson
Clinical Endocrinology, 2014
View PDFchevron_right
Long-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
Mohamed Abid
The American Journal of the Medical Sciences, 2012
View PDFchevron_right
Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Berenice Mendonca
Clinics (São Paulo, Brazil), 2011
View PDFchevron_right
Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period
Pascal Auquier
Endocrine Journal, 2012
View PDFchevron_right
Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
Liat Devries
Endocrine, 2021
View PDFchevron_right
Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Henrik Falhammar
European Journal of Endocrinology, 2011
View PDFchevron_right
Glucocorticoid Replacement Regimens in Chronic Adrenal Insufficiency: A Systematic Review and Meta-Analysis
Alaa Nofal
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016
View PDFchevron_right
Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Phyllis Speiser
The Journal of clinical endocrinology and metabolism, 2018
View PDFchevron_right
Increased Liver Enzymes in Adult Women with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Agneta Nordenskjöld
Endocrine Journal, 2009
View PDFchevron_right
PREDICTIVE FACTORS OF BIOLOGICAL ADRENAL INSUFFICIENCY AFTER A LONG-TERM GLUCOCORTICOID THERAPY.
IJAR Indexing
International Journal of Advanced Research (IJAR), 2019
View PDFchevron_right
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Heino Meyer-bahlburg
The Journal of Clinical Endocrinology and Metabolism, 2010
View PDFchevron_right
Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR
Sharif Uddin
Clinical endocrinology, 2017
View PDFchevron_right
Letter to the editor: MITIGATION OF METABOLIC DYSHOMEOSTASIS BY GLUCOCORTICOID- RECEPTOR ANTAGONISM: INSIGHTS FROM ANIMAL AND HUMAN STUDIES
Aishwariya Madhavan
2020
View PDFchevron_right
Defining the Dose, Type and Timing of Glucocorticoid and Mineralocorticoid Replacement in 256 Children and Adults with Congenital Adrenal Hyperplasia (Cah) in the I-Cah Registry
Tatjana Milenkovic
Hormone Research in Paediatrics, 2017
View PDFchevron_right
Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency
Jean-Claude Carel
European Journal of Endocrinology, 2008
View PDFchevron_right
International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry
Navoda Atapattu
European Journal of Endocrinology
View PDFchevron_right
Bone Health Should Be an Important Concern in the Care of Patients Affected by 21 Hydroxylase Deficiency
Zeina Chakhtoura
International Journal of Pediatric Endocrinology, 2010
View PDFchevron_right
Management of adrenal insufficiency
Nazim Ghouri
Journal of Diabetes and Endocrine Practice, 2021
View PDFchevron_right
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
Henrik Falhammar
The Journal of Clinical Endocrinology & Metabolism
View PDFchevron_right
Glucocorticoid Receptors in Patients with Congenital Adrenal Hyperplasia
Hulya Gunoz
Journal of Pediatric Endocrinology and Metabolism, 2000
View PDFchevron_right